Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pralsetinib. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111440151A details a streamlined 3-step synthesis of Pralsetinib using Rieke Zinc coupling, offering high purity >99.6% and reduced manufacturing costs.